Analysts at HC Wainwright upped their FY2024 earnings estimates for Inovio Pharmaceuticals in a research report issued on ...
Inovio Pharmaceuticals Inc (INO) stock saw a decline, ending the day at $2.09 which represents a decrease of $-0.19 or -8.33% from the prior close of $2.28. The stock opened at $2.36 and touched a low ...
This was the stock's fourth consecutive day of losses.
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities ...
JMP Securities analyst Roy Buchanan reiterated a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of ...
Inovalis Real Estate Investment Trust (the “REIT”) (TSX: INO.UN) today announced the signing of an exchange contract for the sale of 87.5% of the Arcueil property to two parties for €37.5 million ($56 ...
Merck & Co. Inc.-1.32% $255.44B ...
H.C. Wainwright lowered the firm’s price target on Inovio (INO) to $3 from $5 and keeps a Neutral rating on the shares after the company ...